| Zack D Gill, | |
|
1851 Bunker Lake Blvd Nw, Andover, MN 55304-4010 | |
| (763) 354-5720 | |
| Not Available |
| Full Name | Zack D Gill |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1851 Bunker Lake Blvd Nw, Andover, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447858915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 114531 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zack D Gill, 1851 Bunker Lake Blvd Nw, Andover, MN 55304-4010 Ph: (763) 354-5720 | Zack D Gill, 1851 Bunker Lake Blvd Nw, Andover, MN 55304-4010 Ph: (763) 354-5720 |
News Archive
PanGenex Corporation announced today that it anticipates the release of its long form television program, demonstrating the benefits of Calci-CLEAR™, its patent pending dietary supplement that addresses soft tissue calcification, pursuant to its partnership with Incredible Discoveries® in early 2010.
In a meeting with the Obama administration Monday, Gov. Jan Brewer proposed some Medicaid changes that she hopes will allow Arizona to drop fewer people than previously proposed from the state's Medicaid rolls. Brewer's office already has received permission to cut coverage for 250,000 members, mostly childless adults, as the state tries to close an ongoing budget shortfall.
A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70% of women were facing sexual function problems approximately two years post diagnosis.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, presented results of a Phase I open-label dose-escalation study with Debio 0932, an oral Heat Shock Protein 90 (HSP90) inhibitor in clinical development as an anti-cancer agent.
› Verified 3 days ago
Dr. Thomas Edward Lackner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1372 138th Ln Nw, Andover, MN 55304 Phone: 763-755-3662 | |
Mengistu S Kifle, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1851 Bunker Lake Blvd Nw, Andover, MN 55304 Phone: 763-354-5720 | |
Jess Alan Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1851 Bunker Lake Blvd Nw, Andover, MN 55304 Phone: 763-354-5720 Fax: 763-354-5714 | |
Rachel Grimm, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Bunker Lake Blvd Nw, Andover, MN 55304 Phone: 763-852-0114 | |
Scott M Benson Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15245 Bluebird St Nw, Andover, MN 55304 Phone: 763-434-1901 | |
Beth Hansen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2134 Bunker Lake Blvd Nw, Andover, MN 55304 Phone: 763-754-6409 Fax: 763-754-6478 | |
Teri Ann Wiege, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1851 Bunker Lake Blvd Nw, Andover, MN 55304 Phone: 763-354-5720 Fax: 763-354-5714 |